MedReleaf

company

About

MedReleaf is a Canadian licensed producer and distributor of medical cannabis.

  • Markham,Ontario,Canada
  • 51 - 100

Details

Last Funding Type
Post-IPO Secondary
Last Funding Money Raised
$19.99M
Industries
Cannabis,Health Care,Medical,Pharmaceutical
Founded date
Apr 19, 2014
Number Of Employee
51 - 100
Operating Status
Active
Stock Symbol
tsx:LEAF

MedReleaf is a Canadian licensed producer and distributor of medical cannabis operating from a state-of-the-art 55,000 sq. ft. facility in Markham, Ontario. Through over 20 ongoing investigative research initiatives, an extensive plant breeding program and regular patient monitoring and data analysis, MedReleaf is focused on accelerating Their understanding of the numerous potential benefits of medical cannabis and on validating new treatment options for patients.

MedReleaf’s exclusive to Canada, lockable containers are designed to provide added peace-of-mind that only the owner has authorized access to their medication. These patent-pending containers help to keep medication safe for consumption and out of harm’s way or out of the hands of curious passersby.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$100.70M
MedReleaf has raised a total of $100.70M in funding over 2 rounds. Their latest funding was raised on Jun 7, 2017 from a Post-IPO Secondary round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jun 7, 2017 Post-IPO Secondary $19.99M Detail
Jun 7, 2017 IPO $80.70M Detail

Investments

Number of Investments
Number of Lead Investments
1
0
MedReleaf has made 1 investments. Their most recent investment was on Sep 14, 2017, when Fotonica raised 0.
Date Company Name
Round Money Raised Industry Lead Investor
Sep 14, 2017 Fotonica
Seed Agriculture

Employee Profiles

Number of Employee Profiles
3
MedReleaf has 3 current employee profiles, including Executive Neil J. Closner
Executive
Employee
Employee